Dugmont
Résultats de Recherche
Voir tous les résulats
  • Nous rejoindre
    Se connecter
    S’enregistrer
    Rechercher

Rechercher

Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis

  • Fil d’actualités
  • EXPLORER
  • Pages
  • Groupes
  • Evènements
  • Blogs
  • Offres
  • Emplois
  • Jeux
  • Articles
  • Posts
  • Utilisateurs
  • Pages
  • Groupes
  • Evènements
  • Vikas Kokate Ajout d’un nouvel article Autre
    2025-10-07 07:55:57 -
    Immune Checkpoint Inhibitors Market Overview, Growth Analysis, Trends and Forecast By 2029
    "Executive Summary Immune Checkpoint Inhibitors Market Size and Share Analysis Report Immune checkpoint inhibitors market is expected to gain market growth in the forecast period of 2022-2029. Data Bridge Market Research analyses the market to account to grow at a CAGR of 18.2% in the above mentioned forecast period. Businesses are very much depending on the diverse segments involved in...
    0 Commentaires 0 Parts 45 Vue
    Connectez-vous pour aimer, partager et commenter!
  • Vikas Kokate Ajout d’un nouvel article Autre
    2025-08-06 12:11:55 -
    Immuno-Oncology (IO) Market Overview, Growth Analysis, Trends and Forecast By 2030
    "Future of Executive Summary Immuno-Oncology (IO) Market: Size and Share Dynamics Data Bridge Market Research analyses that the immuno-oncology (IO) market, which is USD 28.10 billion in 2022, is expected to reach USD 156.05 billion by 2030, at a CAGR of 23.9% during the forecast period 2023 to 2030 To thrive in this rapidly transforming marketplace, today’s businesses call for innovative...
    0 Commentaires 0 Parts 644 Vue
    Connectez-vous pour aimer, partager et commenter!
  • Vikas Kokate Ajout d’un nouvel article Autre
    2025-09-16 07:46:26 -
    Ipilimumab Market Overview, Growth Analysis, Trends and Forecast By 2029
    "Latest Insights on Executive Summary Ipilimumab Market Share and Size Data Bridge Market Research analyses that the ipilimumab? market was valued at USD 2.026 million in 2021 and is expected to reach USD 4.34 million by 2029, registering a CAGR of 10.0% during the forecast period of 2022 to 2029. Objectives of the Market research are kept in mind while preparing the reliable Ipilimumab...
    0 Commentaires 0 Parts 193 Vue
    Connectez-vous pour aimer, partager et commenter!
© 2025 Dugmont French
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek
Environ Conditions générale de vente Confidentialité Contactez nous Annuaire